FIELD: organic chemistry, medicine, pharmacy.
SUBSTANCE: invention relates to novel compounds of the formula (I): wherein m = 1-4; n = 0-4; A means alkyl, aryl, trifluoromethylfuryl, arylalkyl, arylcycloalkyl, cycloalkylalkyl or aryloxyalkyl; E means -CHOH- or -C(O)-; X means -(CH2)2- or -CH=CH-; Y means -CH2-, arylene, -S-; Z means -COOH; each R1, R2, R3, R4, R5, R6, R7, R8, R9 and R10 means independently hydrogen atom or alkyl, or its pharmaceutically acceptable salt or solvate, individual isomer or racemic or nonracemic mixture of isomers. Also, invention relates to a pharmaceutical composition and using compounds based on the formula (I) possessing activity as agonists of prostaglandin. Invention provides preparing novel biologically active compounds and pharmaceutical compositions based on thereof possessing activity as agonists of prostaglandin.
EFFECT: valuable biological property of compounds and pharmaceutical compositions.
24 cl, 1 tbl, 7 ex
Title | Year | Author | Number |
---|---|---|---|
DERIVATIVES OF 2-PYRROLIDONE AS PROSTANOID AGONISTS AND PHARMACEUTICAL COMPOSITION | 2002 |
|
RU2296122C2 |
PROSTAGLANDIN ANALOGS, METHOD FOR THEIR PREPARING AND PHARMACEUTICAL COMPOSITION POSSESSING SELECTIVE AGONISTIC ACTIVITY WITH RESPECT TO EP-RECEPTOR | 2002 |
|
RU2288913C2 |
CD73 INHIBITOR, ITS PRODUCTION METHOD AND ITS USE | 2020 |
|
RU2787428C1 |
METHOD OF TREATMENT OF SCHIZOPHRENIA | 2012 |
|
RU2648474C2 |
BENZOPYRANS, METHOD OF PREPARATION THEREOF, INTERMEDIATE COMPOUNDS AND PHARMACEUTICAL COMPOSITIONS | 1996 |
|
RU2160735C2 |
ANTIBACTERIAL AGENT | 2000 |
|
RU2269525C2 |
ANTIBACTERIAL AGENTS | 1999 |
|
RU2246941C2 |
METHOD OF TREATMENT OF DISEASES AT MAMMALS | 2004 |
|
RU2344121C2 |
FIBROBLAST GROWTH FACTOR RECEPTOR INHIBITORS AND USE THEREOF | 2017 |
|
RU2732127C1 |
DERIVATIVES OF HYDROXAMIC OR CARBOXYLIC ACID AND PHARMACEUTICAL OR VETERINARY COMPOSITION ON SAID | 1995 |
|
RU2136657C1 |
Authors
Dates
2007-11-27—Published
2004-01-02—Filed